CARDIOVASCULAR JOURNAL OF AFRICA • Vol 23, No 6, July 2012
AFRICA
e9
uremia.
Urol Res
1988;
16
: 119
–
126.
16. Kennedy DJ, Elkareh J, Shidyak A, Shapiro AP, Smaili S, Mutgi K,
et
al.
Partial nephrectomy as a model for uremic cardiomyopathy in the
mouse.
Am J Physiol Renal Physiol
2008;
294
: F450–454.
17. Bro S, Bentzon JF, Falk E, Andersen CB, Olgaard K, Nielsen LB.
Chronic renal failure accelerates atherogenesis in apolipoprotein
E-deficient mice.
J Am Soc Nephrol
2003;
14
: 2466
–
2474.
18. Shih W, Hines WH, Neilson EG. Effects of cyclosporin A on the devel-
opment of immune-mediated interstitial nephritis.
Kidney Int
1988;
33
:
1113
–
1118.
19. Wali MA, Eid RA, Dewan M, Al-Homrany MA. Pre-existing histo-
pathological changes in the cephalic vein of renal failure patients before
arterio-venous fistula (AVF) construction.
Ann Thorac Cardiovasc Surg
2006;
12
: 341
–
348.
20. Lopez I, Aguilera-Tejero E, Mendoza FJ, Almaden Y, Perez J, Martin
D, Rodriguez M. Calcimimetic R-568 decreases extraosseous calcifica-
tions in uremic rats treated with calcitriol.
J Am Soc Nephrol
2006;
17
:
795
–
804.
21. Wang N, Yang J, Yu X, Hu J, Xing C, Ju X,
et al.
Radial artery calcifica-
tion in end-stage renal disease patients is associated with deposition of
osteopontin and diminished expression of alpha-smooth muscle actin.
Nephrology (Carlton)
2008;
13
: 367
–
375.
22. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A,
Raggi P. Effects of sevelamer and calcium on coronary artery calcifica-
tion in patients new to hemodialysis
. Kidney Int
2005;
68
: 1815
–
1824.
23. Chertow GM, Raggi P, Chasan-Taber S, Bommer J, Holzer H, Burke
SK. Determinants of progressive vascular calcification in haemodialy-
sis patients. Nephrol Dial Transplant 2004;
19
: 1489
–
1496.
24. Ohmi K, Masuda T, Yamaguchi H, Sakurai T, Kudo Y, Katsuki M,
Nonomura Y. A novel aortic smooth muscle cell line obtained from
p53 knock out mice expresses several differentiation characteristics.
Biochem Biophys Res Commun
1997;
238
: 154
–
158.
25. Li X, Yang HY, Giachelli CM. BMP-2 promotes phosphate uptake,
phenotypic modulation, and calcification of human vascular smooth
muscle cells. atherosclerosis. Atherosclerosis 2008;
199
: 271
–
277.
26. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R,
et
al.
Smooth muscle cell phenotypic transition associated with calcifi-
cation: upregulation of Cbfa1 and downregulation of smooth muscle
lineage markers.
Circ Res
2001;
89
: 1147
–
1154.
27. Chen NX, O’Neill KD, Duan D, Moe SM. Phosphorus and uremic
serum up-regulate osteopontin expression in vascular smooth muscle
cells.
Kidney Int
2002;
62
: 1724–1731.
28. Li X, Yang HY, Giachelli CM. Role of the sodium-dependent phosphate
cotransporter, Pit-1, in vascular smooth muscle cell calcification.
Circ
Res
2006;
98
: 905–912.
29. Tanaka T, Sato H, Doi H, Yoshida CA, Shimizu T, Matsui H,
et al.
Runx2 Represses Myocardin-Mediated Differentiation and Facilitates
Osteogenic Conversion of Vascular Smooth Muscle Cells.
Mol Cell Biol
2008;
28
: 1147
–
1160.
30. Zambetti GP, Horwitz EM, Schipani E. Skeletons in the p53 tumor
suppressor closet: genetic evidence that p53 blocks bone differentiation
and development
. J Cell Biol
2006;
172
: 795
–
797.
31. Wang X, Kua HY, Hu Y, Guo K, Zeng Q, Wu Q,
et al.
p53 functions as
a negative regulator of osteoblastogenesis, osteoblast-dependent osteo-
clastogenesis, and bone remodeling
. J Cell Biol
2006;
172
: 115–125.
32. Fujita K, Janz S. Attenuation of WNT signaling by DKK-1 and -2 regu-
lates BMP2-induced osteoblast differentiation and expression of OPG,
RANKL and M-CSF.Mol
Cancer
2007;
6
: 1
–
13.
